Relay Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $6,999 | $0 | $677 | $7,679 |
Gross Profit | -7,608 | -748 | 677 | 7,679 |
EBITDA | -57,848 | -73,401 | -75,845 | -83,661 |
EBIT | -54,890 | -74,149 | -76,847 | -84,869 |
Net Income | -54,890 | -74,149 | -70,375 | -77,065 |
Net Change In Cash | 6,999 | 0 | 677 | 7,679 |
Free Cash Flow | -44,866 | -62,118 | -55,287 | -73,594 |
Cash | 84,018 | 91,564 | 113,941 | 93,542 |
Basic Shares | 171,586 | 172,389 | 171,264 | 169,233 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $15,355 | $10,007 | $25,546 | $1,381 |
Gross Profit | 10,007 | 25,546 | 1,381 | |
EBITDA | -276,479 | -380,210 | -374,153 | -306,822 |
EBIT | -385,674 | -379,422 | -310,952 | |
Net Income | -276,479 | -337,708 | -341,973 | -290,509 |
Net Change In Cash | 15,355 | 10,007 | 25,546 | 1,381 |
Cost of Revenue | -128,325 | |||
Free Cash Flow | -235,865 | -251,125 | -304,442 | -238,552 |
Cash | 84,018 | 124,287 | 143,736 | 998,917 |
Basic Shares | 171,586 | 142,867 | 122,576 | 112,233 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$0.31 |
2025-09-30 | -$0.43 |
2025-06-30 | -$0.41 |
2025-03-31 | -$0.45 |
